Formed in April 2012, the Science Committee is responsible for the oversight, development, review, funding and management of a portfolio of research programmes and projects. The Science Committee meets twice a year in April and October/November.
The Science Committee has a broad remit spanning basic and translational cancer research and offers the funding opportunities below.
Programme grants provide long-term support for broad, multidisciplinary research where the aim is to answer an interrelated set of questions. Programme grants are awarded to outstanding individuals with an established scientific track record and are generally intended to be held for five years.
Applications for programmatic funding will be accepted in any of the following areas:
- Basic biological research relating to cancer
- Preclinical studies that will generate biological data to underpin therapeutic development
- Biomarker research
- Imaging research
- Radiotherapy research
Project grant applications are considered by the Biomarker Expert Review Panel and the Drug Discovery Expert Review Panel. Both panels have a fixed membership and meet in advance of the Science Committee to assess the scientific quality of the applications.
If you have any queries about the Science Committee, please contact a member of the team.